Physician profile
Philip Farzad
NPI 1841347176
$2,482.30
in general payments reported to CMS, 2019-2025
15 companies · $240 in 2025
The $240 reported for 2025 was more than what 79% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,689 · 2021: $145 · 2022: $244 · 2023: $164 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirona Dental, INC. | $1,500.00 | 2019 | |
| Abbvie INC. | $125.00 | 2021 | |
| Mannkind Corporation | $125.00 | 2019 | |
| Vanda Pharmaceuticals INC. | $124.96 | 2025 | Fanapt |
| Amgen INC. | $121.77 | 2023 | Otezla |
| Regeneron Healthcare Solutions, INC. | $111.62 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $101.23 | 2022-2023 | Seglentis |
| Align Technology, INC. | $62.27 | 2025 | Invisalign |
| 3m Company | $56.43 | 2019-2022 | |
| Voco America INC. | $48.99 | 2021-2022 | |
| Solventum Corporation | $32.68 | 2025 | 3m Clinpro |
| Dentsply Sirona INC | $32.23 | 2019-2025 | Suresmile |
| Philips North America LLC | $15.77 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $12.36 | 2019 | |
| Colgate Oral Pharmaceuticals, INC. | $11.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Farzad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.